Arjuna
Terminalia arjuna
Arjuna (Terminalia arjuna) is classified in Ayurveda as Hridya (Cardiotonic), from the Combretaceae family. Parts used: bark. Named after Arjuna of Mahabharata. No dedicated WHO monograph identified.
| Botanical name | Terminalia arjuna |
|---|---|
| Family | Combretaceae · other entries in this family |
| Order | Myrtales |
| Ayurvedic category | Hridya (Cardiotonic) |
| Pharmacopoeia status | No dedicated WHO monograph identified. Listed in Ayurvedic Pharmacopoeia of India. Recognized in Indian traditional medicine systems (Ayurveda, Siddha, Unani). Included in Indian Pharmacopoeia for cardiovascular indications. |
| Taxon identifiers | GBIF 3699548 · Wikidata Q2719381 · NCBI Taxonomy 172200 |
| Sanskrit | Kakubha, ककुभः (kakubhaḥ), Partha, Svetavaha |
|---|---|
| Hindi | अर्जुन (arjuna) |
| English | Arjuna |
| Tamil | Marudam, நீர்மருது, மருதம், வெள்ளைமருது |
| Malayalam | Kellemasuthu, Mattimora, Nirmasuthu, Torematti, Vellamaruthi |
| Telugu | Maddi |
| Kannada | Bilimatti, Kudare Kivimase, Mathichakke, Matti, Neermatti |
| Marathi | Arjuna, Sadada |
| Bengali | Arjun |
| Gujarati | Arjuna, Sadad, Sajada |
| Urdu | Arjun |
| Punjabi | Arjon |
| Oriya | Arjuna |
Sources: API Vol II, ARJUNA (Terminalia arjuna), Tamil: Marudam; Tamil Lexicon p.3093 "marutu: 1. Arjuna"; Ayurvedic Pharmacopoeia of India (column alignment reconstructed); MMPND Sorting Terminalia, Terminalia arjuna, HINDI: अर्जुन Arjun, Arjuna (in Devanagari); API Vol II, ARJUNA, Hindi: Arjuna; Pandanus, Hindi: arjun; Monier-Williams p.241, quoted in the Pandanus record for Terminalia arjuna: "the tree Terminalia arjuna MBh. Suśr. &c."; API Vol II, ARJUNA, Sanskrit: Kakubha; Tamil Lexicon p.2306: "நீர்மருது nīr-marutu, n. Arjuna, 1. tr., Terminalia arjuna", the only hit in a full-text Lexicon search for 'Terminalia arjuna'; also Pandanus, Tamil: nīrmarutu; Tamil Lexicon p.3803: "வெள்ளைமருது veḷḷai-marutu, n. பூமருது, 1. 2. Arjuna. See நீர்மருது"; Pandanus record for Terminalia arjuna, Tamil: veḷḷaimarutu. How we source.
The evidence at a glance
12papers on this site for this drug, published 1995 to 2026, every one with a DOI.
- 4Randomised controlled trials
- 8Other clinical studies and reviews
A count is not a conclusion and a tier is a study design, not a verdict. Each paper is listed with what it measured on the page below. See the research index for how papers are tiered.
Names and identification
| Language | Name |
|---|---|
| English | Arjuna |
| Common Names | Arjuna, Arjun tree |
| Hindi | Arjun |
| Sanskrit | Arjuna, Dhananjaya, Partha |
| Latin/Botanical | Terminalia arjuna |
Parts Used
- Bark
Dosha Effects
| Dosha | Effect |
|---|---|
| Pitta | Decreases |
| Kapha | Decreases |
| Vata | Neutral |
Key Phytochemical Constituents
- Arjunolic acid
- Arjunic acid
- Arjungenin
- Arjunetin
- Tannins
- Flavonoids (luteolin)
Therapeutic Actions (Karma)
- Cardiotonic
- Antihypertensive
- Anti-ischemic
- Antioxidant
- Hypolipidemic
- Wound healing
How does it work?
- Arjunolic acid (pentacyclic triterpenoid) is the primary cardioprotective compound, inhibiting thrombin-induced platelet aggregation (IC50: 0.048 mM, more potent than aspirin at 0.088 mM)
- Prevents doxorubicin-induced cardiac apoptosis by blocking JNK-p38 and p53 signaling pathways
- Reverses cardiac fibrosis by inhibiting non-canonical TGF-beta signaling via TAK1 phosphorylation blockade, reducing p38 MAPK and NF-kB p65 activation
- Boosts endogenous antioxidant defense: increases catalase, superoxide dismutase, and glutathione S-transferase activity
- Anti-inflammatory cytokine rebalancing: decreases pro-inflammatory and increases anti-inflammatory cytokines in cardiac tissue
- Cardioprotection via MyD88-dependent TLR4 signaling pathway inhibition (2023 discovery)
- Positive inotropic effect enhancing myocardial contractility without increasing heart rate
How is it used traditionally?
Named after Arjuna of Mahabharata. Vagbhata describes Arjuna Ksheerapaka for Hridroga (heart disease). Charaka classifies it as Udarda Prashamana (anti-urticaria) and wound healer.
Where is it described in the classical texts?
- Charaka Samhita
- Sushruta Samhita
- Ashtanga Hridaya
- Bhavaprakasha Nighantu
What do recent studies show?
- Ramesh P, Palaniappan A 2023. Terminalia arjuna, a Cardioprotective Herbal Medicine-Relevancy in the Modern Era of Pharmaceuticals and Green Nanomedicine-A Review. Pharmaceuticals (Basel, Switzerland). PMID 36678623 · doi:10.3390/ph16010126
Review examining T. arjuna’s pleiotropic cardiovascular effects including anti-atherogenic, hypotensive, inotropic, anti-inflammatory, anti-thrombotic and antioxidant actions, with exploration of nano-formulation approaches for improved bioavailability. - Rajaram V, Namasivayam A, Shanmugam R and others 2024. Terminalia arjuna: An overview of its magical properties. Bioinformation. PMID 40230946 · doi:10.6026/9732063002002080
Comprehensive overview documenting cardiovascular properties attributed to flavonoids, polyphenols, triterpenoids, tannins, glycosides, and minerals. Highlighted need for more rigorous clinical trials. - Hasan MM, Madhavan P, Ahmad Noruddin NA and others 2023. Cardioprotective effects of arjunolic acid in LPS-stimulated H9C2 and C2C12 myotubes via the My88-dependent TLR4 signaling pathway. Pharmaceutical biology. PMID 37497554 · doi:10.1080/13880209.2023.2230251
Demonstrated arjunolic acid exerts cardioprotection by inhibiting MyD88-dependent TLR4 signaling, reducing LPS-induced cardiac inflammation and oxidative stress in cellular models. - Maulik SK, Wilson V, Seth S and others 2016. Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trial. Phytomedicine : international journal of phytotherapy and phytopharmacology. PMID 26988798 · doi:10.1016/j.phymed.2016.02.007
When added to standard pharmacotherapy in chronic heart failure for 12 weeks, Arjuna extract showed no significant change in LVEF but improved functional capacity, antioxidant reserves, and symptom-related quality of life. (Most recent large RCT available)
Only studies that could be traced to a published paper are listed here. An absence here means we could not identify the source, not that no work exists.
Recent safety updates
- No serious side effects reported with arjuna therapy in clinical studies; long-term safety data still limited
- Adverse reactions similar to placebo: constipation, headache, abdominal discomfort, body ache
- Drug interaction WARNING: may potentiate anticoagulant effects of warfarin due to inherent antiplatelet and anticoagulant properties similar to aspirin
- Inhibits CYP3A4, CYP2D6, and CYP2C9 enzymes in human liver microsomes in vitro - caution with drugs metabolized by these enzymes
- In vivo pharmacokinetic study showed aqueous extract did not significantly alter pharmacokinetic parameters of probe substrates, suggesting in vitro findings may not fully translate
- High doses in animal studies associated with hepatotoxicity and hypothyroidism in rats
- Co-administration with statins, calcium channel blockers, and other CYP3A4 substrates requires medical supervision
Recommended Dosage
Bark powder at the dose given under Standard Dosage (with milk or water); Ksheerapaka (milk decoction): 10-20ml twice daily
Safety, contraindications and cautions
- May potentiate cardiac medications
- Hypotension risk with antihypertensives
- Pregnancy (limited data)
What is it made of?
Part(s) Analyzed: Bark
Key Active Markers
- Arjunetin
- Tannins
- Flavonoids
- Luteolin
- Arjunolic acid
- Arjunic acid
- Arjungenin
Dosage forms and preparation
Dosage Forms: Churna (bark powder), Capsule, Tablet, Kashayam (decoction), Kshirapaka (milk decoction), Arishta (Arjunarishta, fermented), Ghana Vati (concentrated extract tablet)
Standard Dosage: 3-6g bark powder twice daily with milk; 500mg-1g extract capsule twice daily; 15-30ml Arjunarishta after meals; Kshirapaka: 3-6g boiled in milk
Optimal Timing: Kshirapaka or powder with milk early morning and evening for cardiac support. Arjunarishta after meals.
Storage: Bark powder in airtight containers, cool and dry place below 25°C. Arjunarishta in amber glass at room temperature, improves with age. Capsules with desiccant.
Marker Compounds: Arjunolic acid, Arjunic acid, Arjungenin, Arjunetin, Arjunaphthanol, Casuarinin, Gallic acid, Ellagic acid, Luteolin, Beta-sitosterol
Synergistic Combinations
- With Ashwagandha for cardioprotection and stress management
- With Punarnava, traditionally used for heart conditions and edema
- With Amalaki for antioxidant cardioprotection
- With Pushkaramoola, traditionally used for heart conditions
- With Guggulu for lipid management
Published research
Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.
Randomised controlled trials4
- 2017. Effect of E-OJ-01 on Cardiac Conditioning in Young Exercising Adults: A Randomized Controlled TrialAmerican journal of therapeutics. PMID 27930383 · doi:10.1097/MJT.0000000000000542
- 2016. Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trialPhytomedicine : international journal of phytotherapy and phytopharmacology. PMID 26988798 · doi:10.1016/j.phymed.2016.02.007
- 2005. Role of Terminalia arjuna in ischaemic mitral regurgitationInternational journal of cardiology. PMID 15837100 · doi:10.1016/j.ijcard.2004.10.045
- 1995. Salutary effect of Terminalia Arjuna in patients with severe refractory heart failureInternational journal of cardiology. PMID 7649665 · doi:10.1016/0167-5273(95)02320-v
Other clinical studies and reviews8
- 2026. Hepatoprotective Potential of Indian Medicinal PlantsCombinatorial chemistry & high throughput screening. PMID 39835553 · doi:10.2174/0113862073346295250107070310
- 2023. Terminalia arjuna, a Cardioprotective Herbal Medicine-Relevancy in the Modern Era of Pharmaceuticals and Green Nanomedicine-A ReviewPharmaceuticals (Basel, Switzerland). PMID 36678623 · doi:10.3390/ph16010126
- 2023. Therapeutic potential and industrial applications of Terminalia arjuna barkJournal of ethnopharmacology. PMID 36933876 · doi:10.1016/j.jep.2023.116352
- 2021. Plants Used as AntihypertensiveNatural products and bioprospecting. PMID 33174095 · doi:10.1007/s13659-020-00281-x
- 2021. Antiviral Potential of Selected Medicinal Herbs and Their Isolated Natural ProductsBioMed research international. PMID 34926691 · doi:10.1155/2021/7872406
- 2017. Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A reviewJournal of traditional and complementary medicine. PMID 28053890 · doi:10.1016/j.jtcme.2016.02.003
- 2016. Traditional herbs: a remedy for cardiovascular disordersPhytomedicine : international journal of phytotherapy and phytopharmacology. PMID 26656228 · doi:10.1016/j.phymed.2015.10.012
- 2015. The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae)Inflammopharmacology. PMID 26226895 · doi:10.1007/s10787-015-0246-z
Reviewed by Dr. Awadesh Pratap Singh, BAMS, on 11 October 2026. What that review covered.
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.